Overview / Abstract: |
Originally presented at a virtual symposium following the IDWeek™ 2020, Paul Feuerstadt, MD, Kevin W. Garey, PharmD, and Krishna Rao, MD, discuss guideline-directed prevention and treatment of recurrent Clostridium difficile (C. diff). Other discussion topics include risk factors for C. diff recurrence as well as antimicrobial interventions to reduce recurrence and improve outcomes. |
Expiration |
Dec 07, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.25 |
Accreditation |
ACCME, ACPE |
Presenters / Authors / Faculty |
Paul Feuerstadt, MD, FACG, AGAF (Chair) Kevin W. Garey, PharmD, MS Krishna Rao, MD, MS |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Merck & Company. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, Continuing Education, Live CME, Live CE, Live Meetings, Streaming CME, Streaming CE, Webinar, Webcast, IDWeek™ 2020, IDSA, Infectious Diseases Society of America, Symposium, Virtual CME, Virtual CE, Merck, Merck & Company, Clostridioides, Clostridium difficile, C. diff, infectious diseases, ID specialists, hospitalists, internists, pharmacists, gastrointestinal infection, bezlotoxumab Free CE CME |